Westmount Partners »

Bridgebio Pharma shares owned by Westmount Partners

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Westmount Partners from 13F filings

Historical chart of Westmount Partners investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Westmount Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Westmount Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $241k 3.2k 76.49

More positions owned by Westmount Partners

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Caci Intl Cl A (CACI)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Vanguard Index Fds Total Stk Mkt (VTI)
Wal-Mart Stores (WMT)
International Business Machines (IBM)

View all positions for Westmount Partners

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Viking Global Investors
Kohlberg Kravis Roberts & Co
Farallon Capital Management
Henderson Group
UBS Group
Aisling Capital Management
State Street Corporation
Invesco
Geode Capital Management
Jane Street
Susquehanna International
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma